Table 1.
Demographic and Clinical Characteristics of the At-Risk Sample
| Characteristic | Nonconverted | Converted to psychotic disorder | Total |
|---|---|---|---|
| Gender, n | |||
| Male | 30 | 8 | 38 |
| Female | 12 | 6 | 18 |
| Baseline age in years, M (SD) | 14.02 (1.79) | 14.36 (1.55) | |
| Age in years at conversion, M (SD) | 16 (0.52) | ||
| Ethnicity, n | |||
| African American | 13 | 3 | 16 |
| Caucasian | 25 | 11 | 36 |
| Asian American | 3 | 0 | 3 |
| Other | 1 | 0 | 1 |
| Baseline medication, n | |||
| Stimulant | 12 | 4 | 16 |
| SSRI | 10 | 2 | 12 |
| Antipsychotic | 8 | 1 | 9 |
| SIPS negative symptoms, M (SD) | 9.33* (5.8) | 14.36* (8.6) | |
| BDI, M (SD) | 13** (7.5) | 21** (8.8) | |
Note. SSRI = selective serotonin reuptake inhibitor; SIPS = Structured Interview for Prodromal Syndromes; BDI = Beck Depression Inventory.
p < .05.
p < .01.